ЭКСТРАКТ РАСТЕНИЯ CIMICIFUGA RACEMOSA – АЛЬТЕРНАТИВА ГОРМОНАЛЬНЫМ ПРЕПАРАТАМ В ЛЕЧЕНИИ ЭСТРОГЕНДЕФИЦИТНЫХ СОСТОЯНИЙ
Аннотация
Об авторах
А. В. ЛединаРоссия
к.м.н.,
Москва;
Московская обл.
М. Б. Хамошина
Россия
д.м.н.,
Москва
Е. В. Ледин
Россия
к.м.н.,
Москва
Список литературы
1. Юренева С.В., Дубровина А.В. Применение ультранизких доз препаратов при проведении менопаузальной гормональной терапии. Проблемы репродукции, 2015, 21(3): 132-136.
2. Gast GC et al. Monopausal complaints are associated with cardiovascular risk factors. Hypertension, 2008, 51: 1492-1498.
3. Martines-Perez JA, Chavida F, Perz M. Severity of menopausal symptoms and cardiovascular and osteoporosis risk factors. Climacteric, 2013, 16(2): 226-234.
4. Сметник В.П. Положения глобального консенсуса о менопаузальной гормонотерапии: цель и обоснование. Акушерство и гинекология, 2015, 7: 83-87.
5. Alipour S., Jafari-Adli S., Eskandari A. Benefits and harms of phytoestrogen consumption in breast cancer survivors. Asian Pac. J. Cancer Prev., 2015, 16(8): 3091-3096.
6. Zhang Y et al. Genistein, a soya isoflavone, prevents azoxymethane-induced up-regulation of WNT/β-catenin signalling and reduces colon pre-neoplasia in rats. Br. J. Nutr., 2013, 14, 109(1): 33-42.
7. Pavese JM, Krishna SN, Bergan RC. Genistein inhibits human prostate cancer cell detachment, invasion, and metastasis. Am. J. Clin. Nutr., 2014, 100(Suppl 1): 431S-436S.
8. Большая энциклопедия народной медицины. М.: Эксмо, 2006. 1088 с.
9. Xi S et al. Effect of Isopropanolic Cimicifuga racemosa Extract on Uterine Fibroids in Comparison with Tibolone among Patients of a Recent Randomized, Double Blind, ParallelControlled Study in Chinese Women with Menopausal Symptoms. Evid. Based. Complement. Alternat. Med., 2014, 2014: 717686.
10. Рафаэлян И.В., Балан В.Е., Ковалева Л.А. Эффективность и безопасность применения экстракта цимицифуги рацемозы в терапии климактерического синдрома в течение года (результаты собственного исследования). Медицинский совет, 2014, 7: 54-57.
11. Li JX et al. Triterpenoids from Cimicifugae rhizoma, a novel class of inhibitors on bone resorption and ovariectomy-induced bone loss. Maturitas, 2007, 20, 58(1): 59-69.
12. Wuttke W, Gorkow C, Seidlová-Wuttke D. Effects of black cohosh (Cimicifuga racemosa) on bone turnover, vaginal mucosa, and various blood parameters in postmenopausal women: a double-blind, placebo-controlled, and conjugated estrogens-controlled study. Menopause, 2006, 13(2): 185-196.
13. Wuttke W, Seidlová-Wuttke D, Gorkow C. The Cimicifuga preparation BNO 1055 vs. conjugated estrogens in a double-blind placebo-controlled study: effects on menopause symptoms and bone markers. Maturitas, 2003, 14, 44(Suppl 1): S67-77.
14. Jin Y et al. Estrogen receptor genotypes influence hot flash prevalence and composite score before and after tamoxifen therapy. J Clin Oncol, 2008, 26: 5849.
15. Rostock M et al. Black cohosh (Cimicifuga racemosa) in tamoxifen-treated breast cancer patients with climacteric complaints a prospectiveobservational study. Gynecol Endocrinol, 2011, 27(10): 844-848.
16. Liske E et al. Physiological investigation of a unique extract of black cohosh (Cimicifugae racemosae rhizoma): a 6-month clinical study demonstrates no systemic estrogenic effect. J. Womens Health Gend. Based. Med., 2002, 11(2): 163-174.
17. Hernández Munoz G, Pluchino S. Cimicifuga racemosa for the treatment of hot flushes in women surviving breast cancer. Maturitas, 2003, 44(Suppl 1): S59-S65.
18. Rockwell S, Liu Y, Higgins SA. Alteration of the effects of cancer therapy agents on breast cancer cells by the herbal medicine black cohosh. Breast Cancer Res. Treat., 2005, 90(3): 233-239.
19. Hostanska K et al. Cimicifuga racemosa extract inhibits proliferation of estrogen receptor-positive and negative human breast carcinoma cell lines by induction of apoptosis. Breast Cancer Res. Treat., 2004, 84(2): 151-160.
20. Drewe J, Bucher KA, Zahner C. A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients. Springerplus, 2015, 10(4): 65.
21. L’Espérance S et al Pharmacological and nonhormonal treatment of hot flashes in breast cancer survivors: CEPO review and recommendations CEPO review and recommendations. Support Care Cancer, 2013, 21: 1461-1474.
22. Fritz H et al. Black Cohosh and Breast Cancer: A Systematic Review. Integrative Cancer Therapies, 2014, 13(1): 12-29.
23. Shahin AY et al. Adding phytoestrogens to clomiphene induction in unexplained infertility patients-a randomized trial. Reprod. Biomed. Online, 2008, 16(4): 580-588.
24. Kamel HH. Role of phyto-oestrogens in ovulation induction in women with polycystic ovarian syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol., 2013, 168(1): 60-63.
25. Merchant S, Stebbing J. Black cohosh, hot flushes, and breast cancer. Lancet Oncol, 2015, 16(2): 137-138.
26. Mohammad-Alizadeh-Charandabi S et al. Efficacy of black cohosh (Cimicifuga racemosa L.) in treating early symptoms of menopause: a randomized clinical trial. Clin.med., 2013, 8(1): 20.
27. Shahnazi M et al. Effect of black cohosh (cimicifuga racemosa) on vasomotor symptoms in postmenopausal women: a randomized clinical trial. J. Caring Sci, 2013, 1, 2(2): 105-113.
28. Прилепская В.Н., Ледина А.В, Михайлова О.И. Материалы Международного конгресса «Профилактика, диагностика и лечение гинекологических заболеваний». М., 2003. С. 206.
29. Рафаэлян И.В. и соавт. Оценка эффективности и безопасности длительного применения экстракта Cimicifuga racemosa в терапии больных с климактерическим синдромом. Российский вестник акушера-гинеколога, 2013, 6: 86-90.
Для цитирования:
Ледина А.В., Хамошина М.Б., Ледин Е.В. ЭКСТРАКТ РАСТЕНИЯ CIMICIFUGA RACEMOSA – АЛЬТЕРНАТИВА ГОРМОНАЛЬНЫМ ПРЕПАРАТАМ В ЛЕЧЕНИИ ЭСТРОГЕНДЕФИЦИТНЫХ СОСТОЯНИЙ. Медицинский Совет. 2017;(2):132-135. https://doi.org/10.21518/2079-701X-2017-2-132-135
For citation:
Ledina A.V., Khamoshina M.B., Ledin E.V. CIMICIFUGA RACEMOSA EXTRACT AS AN ALTERNATIVE TO HORMONE THERAPY IN THE MANAGEMENT OF ESTROGEN DEFICIENCIES. Meditsinskiy sovet = Medical Council. 2017;(2):132-135. (In Russ.) https://doi.org/10.21518/2079-701X-2017-2-132-135